16065-Lymphomas-Non-Hodgkins-404

Lymphomas

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgkin�s Lymphoma (UTX-TGR-205)

  • Details

ClinicalTrials.gov ID: NCT02793583
Diagnosis Type: Non-Hodgkins
USOR Number:

  • Address

1448 East Common St
New Braunfels, TX 78130
P: (830) 643-1762

Search by practice name, trial titles, indicators and specific disease types.